NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1086 coverIntegrated Molecular Medicine for Neuronal and Neoplastic Disorders Volume 1086 published November 2006
Ann. N.Y. Acad. Sci. 1086: 1–10 (2006). doi: 10.1196/annals.1377.011
Copyright © 2006 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by TANAKA, F.
Articles by SOBUE, G.
Search for Related Content
PubMed
PubMed Citation
Articles by TANAKA, F.
Articles by SOBUE, G.

Part I. Motor Neuron Diseases

Gene Expression Profiling toward Understanding of ALS Pathogenesis

FUMIAKI TANAKAa, JUN-ICHI NIWAa, SHINSUKE ISHIGAKIa, MASAHISA KATSUNOa, MASAHIRO WAZAa, MASAHIKO YAMAMOTOa, MANABU DOYUa AND GEN SOBUEa

a Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

Key Words: ALS • SOD1 • gene expression analysis • cDNA microarray • molecular indexing • laser capture microdissection

Address for correspondence: Dr. Gen Sobue, Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Voice: +81-52-744-2385; fax: +81-52-744-2384.  e-mail: sobueg{at}med.nagoya-u.ac.jp

Although more than 130 years have gone by since the first description in 1869 by Jean-Martin Charcot, the mechanism underlying the characteristic selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) has remained elusive. Modest advances in this research field have been achieved by the identification of copper/zinc superoxide dismutase 1 (SOD1) as one of the causative genes for rare familial ALS (FALS) and by the development and analysis of mutant SOD1 transgenic mouse models. However, in sporadic ALS (SALS) with many more patients, causative or critical genes situated upstream of the disease pathway have not yet been elucidated and no available disease models have been established. To approach genes causative or critical for ALS, gene expression profiling in tissues primarily affected by the disease has represented an attractive research strategy. We have been working on screening these genes employing and combining several new technologies such as cDNA microarray, molecular indexing, and laser capture microdissection. Many of the resultant genes are of intense interest and may provide a powerful tool for determining the molecular mechanisms of ALS. However, we have barely arrived at the starting point and are confronting an enormous number of genes whose roles remain undetermined. Challenging tasks lie ahead of us such as identifying which genes are really causative for ALS and developing a disease model of SALS with due consideration for the expression changes in those genes.






footerLeft footerRight